Concurrent rearrangements of BCL2, BCL3, and BCL11A genes in atypical chronic lymphocytic leukemia

被引:13
|
作者
Podgornik, Helena [1 ]
Pretnar, Jozef [1 ]
Skopec, Barbara [1 ]
Andoljsek, Dusan [1 ]
Cernelc, Peter [1 ]
机构
[1] Univ Med Ctr Ljubljana, Dept Haematol, Ljubljana 1000, Slovenia
关键词
Atypical CLL; IGH translocation; t(2; 14); t(14; 19); t(18; 22); CHROMOSOMAL TRANSLOCATIONS; T(14/19)(Q32; Q13); PROGNOSIS; SURVIVAL; FEATURES; T(14/18);
D O I
10.1179/1607845413Y.0000000078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The most frequent chromosomal aberrations with the well established prognostic meaning in chronic lymphocytic leukemia (CLL) are + 12, del(11q), del(13q), and del(17p). Less common translocations lead to deregulation of genes primarily due to juxtaposition with IGH gene. We present a case of CLL patient with atypical morphology and an aggressive course of disease. In spite of aggressive treatment including allogeneic hematopoietic stem cell transplantation disease progressed into a rare cutaneous Richter's syndrome. Trisomy 12 was found as a sole chromosomal change at initial cytogenetic analysis of lymphoma cells. At progression, besides trisomy 12 three concomitant balanced translocations t(2; 14)(p13; q32), t(14; 19)(q32; q13), and t(18; 22)(q21; q11) were found. The same karyotype was confirmed in cells aspirated from skin infiltrates at Richter transformation. Atypical cytological features, trisomy 12, and a progressive course of disease observed in our case are typical for CLL with each of particular Ig translocations that were concomitantly found in CLL for the first time. Similar to "double hit" lymphoma concurrent rearrangements may be relevant also in CLL.
引用
收藏
页码:45 / 48
页数:4
相关论文
共 50 条
  • [41] Mediastinal B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
    Jon L. Ocal
    Andrew L. Feldman
    Patricia T. Greipp
    Lisa M. Rimsza
    Journal of Hematopathology, 2022, 15 : 151 - 155
  • [42] Mediastinal B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
    Ocal, Jon L.
    Feldman, Andrew L.
    Greipp, Patricia T.
    Rimsza, Lisa M.
    JOURNAL OF HEMATOPATHOLOGY, 2022, 15 (03) : 151 - 155
  • [43] Molecular analysis in the diagnosis of follicular lymphomas lacking BCL2 and BCL6 rearrangements
    Cristian, M.
    Hebeda, K. M.
    Groenen, P. J.
    VIRCHOWS ARCHIV, 2024, 485 : S424 - S424
  • [44] Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia
    Roman Alpatov
    Billie Carstens
    Kimberly Harding
    Carolyn Jarrett
    Sudabeh Balakhani
    Jessica Lincoln
    Peter Brzeskiewicz
    Yu Guo
    Alex Ohene-Mobley
    Jamie LeRoux
    Veronica McDaniel
    Lynne Meltesen
    Diane Minka
    Mahendra Patel
    Cyrus Manavi
    Karen Swisshelm
    Molecular Cytogenetics, 8
  • [45] Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia
    Alpatov, Roman
    Carstens, Billie
    Harding, Kimberly
    Jarrett, Carolyn
    Balakhani, Sudabeh
    Lincoln, Jessica
    Brzeskiewicz, Peter
    Guo, Yu
    Ohene-Mobley, Alex
    LeRoux, Jamie
    McDaniel, Veronica
    Meltesen, Lynne
    Minka, Diane
    Patel, Mahendra
    Manavi, Cyrus
    Swisshelm, Karen
    MOLECULAR CYTOGENETICS, 2015, 8
  • [46] STRUCTURAL ALTERATIONS IN THE 5' REGION OF THE BCL2 GENE IN FOLLICULAR LYMPHOMAS WITH BCL2-MBR OR BCL2-MCR REARRANGEMENTS
    MIKRAKI, V
    LADANYI, M
    CHAGANTI, RSK
    GENES CHROMOSOMES & CANCER, 1991, 3 (02): : 117 - 121
  • [47] Matrix isolation study of the interaction of excited neon atoms with BCl3: Infrared spectra of BCl3+, BCl2+, and BCL(3)(+)
    Jacox, ME
    Irikura, KK
    Thompson, WE
    JOURNAL OF CHEMICAL PHYSICS, 1996, 104 (22): : 8871 - 8878
  • [48] Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma
    Jing Zhang
    Xueying Lu
    Jianyong Li
    Yi Miao
    Biomarker Research, 10
  • [49] Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors
    Mauro, Francesca R.
    Frustaci, Anna Maria
    Visentin, Andrea
    Vitale, Candida
    Bartoletti, Michele
    Oltolini, Chiara
    Zappulo, Emanuela
    Mikulska, Malgorzata
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 201
  • [50] Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma
    Zhang, Jing
    Lu, Xueying
    Li, Jianyong
    Miao, Yi
    BIOMARKER RESEARCH, 2022, 10 (01)